DeSantis Breindel, the leading B2B branding and marketing agency in NYC, recently hired Kirsten Nowak as Senior Strategy Director. Kirsten brings a rich background in positioning and managing B2B, consumer, and not-for-profit brands, working across branding, marketing, and advertising disciplines.
Kirsten has deep experience helping clients turn their brands into assets for growth, defining compelling promises for the market and effectively operationalizing the value of these promises for each of a brand’s most critical audiences. As Senior Strategy Director, she will lead strategy and marketing engagements for clients across a range of B2B verticals.
Prior to joining DeSantis Breindel, Kirsten was with Landor Associates, Doremus, and HA Roth Consulting. She has developed comprehensive brand strategy initiatives for a wide variety of global clients including Novartis, Pfizer, Dana-Farber Cancer Institute, Hartford HealthCare, Mount Sinai Health Network, Kean Consulting, Fallon Community Health Plan, The Paley Center, Silver Point Capital, Lux FTS, TRW Automotive, and United Technologies.
“Kirsten brings extensive experience working with global companies across many different industries,” said Howard Breindel, co-CEO of DeSantis Breindel. “The breadth and depth of her expertise will enable the firm to continue to provide the smartest solutions to our clients’ increasingly complex needs.”